IL17A and pemphigus foliaceus: Previous experimental and clinical studies have identified that increased levels of IL17A, M-CSF, CCL17, CCL19, CX3CL1, and CXCL5 contribute to PF development by promoting myofibroblast activation either directly or via recruiting pro-fibrotic immune cells (43, 51–57).